Trials / Conditions / Allergic Rhinitis Due to House Dust Mite

Allergic Rhinitis Due to House Dust Mite

11 registered clinical trials studyying Allergic Rhinitis Due to House Dust Mite — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	The Efficacy of Specific Immunotherapy Guided by Component-Resolved Diagnosis for Dust Mite Allergens in Chine NCT07452380	The Children's Hospital of Zhejiang University School of Medicine	—
Not Yet Recruiting	Noninterventional Study on Tolerability and Safety of One Strength Updosing With Novo-Helisen Depot House Dust NCT07096440	Allergopharma GmbH & Co. KG	—
Unknown	Evaluate Measurement Instruments Relevance in Assessing Effectiveness of ACARIZAX® in House Dust Mite Allergic NCT06151938	ALK-Abelló A/S	—
Unknown	Nasal Irrigation With Combination of 0.9% NaCl and Binahong Extract (Anredera Cordifolia) 2,5% In Allergic Rhi NCT05960526	Gadjah Mada University	Phase 1
Not Yet Recruiting	Radiofrequency Ablation of Bilateral Inferior Turbinate Followed by Subcutaneous Immunotherapy Trial NCT05510024	Eye & ENT Hospital of Fudan University	N/A
Unknown	Mediators in Nasal Hyperreactivity in Allergic Rhinitis and Chronic Rhinosinusitis NCT04286542	Universitaire Ziekenhuizen KU Leuven	N/A
Completed	House Dust Mite Allergy Trial In Children NCT04145219	ALK-Abelló A/S	Phase 3
Completed	N.I.S of AIT in Adult Patients With House Dust Mite Allergy in Real Practice in France NCT03746860	ALK-Abelló A/S	—
Completed	Mite Asthma Pediatric Immunotherapy Trial NCT03654976	ALK-Abelló A/S	Phase 3
Completed	Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adolescents NCT01919554	Stallergenes Greer	Phase 1
Completed	Efficacy and Safety of 100IR, 300IR, 500IR Sublingual House Dust Mite Tablets in Allergic Rhinitis Environment NCT01527188	Stallergenes Greer	Phase 2